Last reviewed · How we verify
NCT04612322: MICRO
MICRO: a Registry Study in Patients With Microvascular Angina
trial testing Assessment of microvascular function with intracoronary hemodilution in Microvascular Disease in 1,000 participants. Currently enrolling.
10 October 2024
Quick facts
| Lead sponsor | Johannes Gutenberg University Mainz |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 10 October 2020 |
| Primary completion | 10 October 2024 |
| Estimated completion | 10 October 2029 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Assessment of microvascular function with intracoronary hemodilution
Conditions studied
- Microvascular Disease — all drugs for Microvascular Disease →
Sponsor
Johannes Gutenberg University Mainz
Who can join
Adults 18 to 85, any sex, with Microvascular Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The evidence above demonstrates that microvascular dysfunction is an important determinant of patient prognosis, which however remains poorly classified. Given the high burden of disease and the severity of the functional impairment in these patients, the lack of a clear definition for this disease has a potentially large clinical importance. It is important to better describe the phenotype of these patients, identify the predictors of prognosis, and determine the impact of diagnosis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04612322
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Johannes Gutenberg University Mainz trials
Trials by the same sponsor.
- NCT06269874 — Study Comparing Two Administration Pathways for Adenosine During Microvascular Function Assessment · NA · not yet recruiting
- NCT07076511 — A Novel Intuitive Airway Trolley for Quick Decision-making in Simulated Unexpected Difficult Airway Situations: Evaluati · NA · completed
- NCT06739993 — Effects of Autonomic Nervous System Modulation by Heart Rate Variability Biofeedback Training With Resonant Frequency Br · NA · recruiting
- NCT06514495 — Differential Effects of in Vivo and Virtual Exposure Therapy in Agoraphobia · NA · recruiting
- NCT07460791 — Alcon Hydrus Stent Implantation - Long Term Follow up After 8 Years · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04612322 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Johannes Gutenberg University Mainz
- Last refreshed: 31 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04612322.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing